LONDON (Reuters) - One year on from a breast implant scandal that shook confidence in Europe's light-touch system for regulating medical devices, lawmakers and manufacturers are at loggerheads on ways to protect patients from shoddy products. Companies that make implantable devices such as new hips and heart stents accept the need for change to the current set-up but oppose a radical overhaul, arguing that would delay the launch of new devices by years and stifle innovation. ...
Read the full article...
(From Yahoo)